Please wait a minute...
European Journal of Gynaecological Oncology  2021, Vol. 42 Issue (2): 379-381    DOI: 10.31083/j.ejgo.2021.02.2387
Case Report Previous articles | Next articles
A rare case of abdominal radical trachelectomy following C-section for early-stage cervical cancer
Mihai Stanca1, *, †(), Mihai Gheorghe1, Szilard Leo Kiss1, Alexandra Lavinia Cozlea1, Victoria Ciobanu1, Kiarash Bahrehmand2, Mihai Emil Căpîlna1, †
1First Obstetrics and Gynecology Clinic, University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540142 Targu Mures, Romania
2Department of Gynecology, Hungarian National Institute of Oncology, 1061 Budapest, Hungary
Download:  PDF(518KB)  ( 134 ) Full text   ( 9 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Background: Cervical cancer is the most frequent cancer type encountered during pregnancy, with an incidence of between 1.4–4.6 cases per 100,000 births. Although there are regulations regarding the correct therapeutic procedure to follow in such circumstances, their application is often hampered by the patient's wishes. Case presentation: The authors describe the case of a pregnant patient (gestational age 25 weeks) who refused neoadjuvant chemotherapy for early-stage cervical cancer. She underwent a failed abdominal radical trachelectomy due to the large uterine volume and inadequate access to the parametria. The final surgical treatment was achieved at 32 gestational weeks when a C-section was performed. This was immediately followed by an abdominal radical trachelectomy with pelvic lymphadenectomy aimed at fertility preservation. Conclusions: The guidelines recommend neoadjuvant chemotherapy as the only pregnancy-preserving option for pregnancies past 22 gestational weeks. However, the patient in this case wished to protect the fetus from possible risks arising due to neoadjuvant chemotherapy. Hence, at the gestational age of 25 weeks she underwent a surgical procedure laden with many risks. The role of abdominal trachelectomy for early stage cervical cancer during pregnancy is still under debate due to the lack of multicenter randomized trials, despite its proven effectiveness in a relatively small number of cases.
Key words:  Abdominal radical trachelectomy      Pregnancy      Fertility preservation      Cervical cancer      C-section     
Submitted:  20 January 2021      Revised:  05 February 2021      Accepted:  06 February 2021      Published:  15 April 2021     
*Corresponding Author(s):  Mihai Stanca     E-mail:  doctorstanca@gmail.com
About author:  These authors contributed equally.

Cite this article: 

Mihai Stanca, Mihai Gheorghe, Szilard Leo Kiss, Alexandra Lavinia Cozlea, Victoria Ciobanu, Kiarash Bahrehmand, Mihai Emil Căpîlna. A rare case of abdominal radical trachelectomy following C-section for early-stage cervical cancer. European Journal of Gynaecological Oncology, 2021, 42(2): 379-381.

URL: 

https://ejgo.imrpress.com/EN/10.31083/j.ejgo.2021.02.2387     OR     https://ejgo.imrpress.com/EN/Y2021/V42/I2/379

[1] Luibov.I. Korolenkova, Ivan.S. Stilidi, Inna.N. Lazareva. Diagnostic value of colposcopy for cervical intraepithelial neoplasia 2–3/carcinoma in situ and microinvasive cervical cancer[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 909-916.
[2] Kelly Baillie, Nicholas Reed, Jennifer Laskey, Jiafeng Pan, Kimberley Kavanagh, Marion Bennie, Christine Crearie, Tanja Mueller, Azmat Sadozye, Rosie Harrand, Ashleigh Kerr, Kathryn Graham. Neoadjuvant chemotherapy in locally advanced cervical cancer: real-world data from the Cancer Medicines Outcomes Programme (CMOP)[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 926-935.
[3] Elif Eda Ozer, Melisa Bagci, Esengul Kocak Uzel, Gulsen Pinar Soydemir, Metin Figen, Meltem Kirli Bolukbas. Comparison of point a based plans with clinical target volume-based three-dimensional plans using dose—volume parameters in small lesion of cervical cancer brachyterapy[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 936-942.
[4] Polo Cornelisz Vermolen, Nienke E. van Trommel, Wouter V. Vogel, Judit A. Adam, Jacobus van der Velden, Constantijne H. Mom. The issue of false positive lymph nodes on [18F] FDG-PET/CT for cervical carcinoma and consequences for treatment[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 943-950.
[5] Jing Fang, Jinmei Fang, Ailin Wu, Yufei Zhao, Yun Liu. Clinical analysis of predisposing factors for radiation enteritis in patients with cervical cancer[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 951-956.
[6] Priscila Thais Silva Mantoani, Daniela Rodrigues Siqueira, Millena Prata Jammal, Eddie Fernando Candido Murta, Rosekeila Simões Nomelini. Immune response in cervical intraepithelial neoplasms[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 973-981.
[7] Francesco Venturelli, Multisociety Italian Guidelines for cervical cancer prevention Working Group. HPV vaccination in women treated for Cervical Intraepithelial Neoplasia grade 2 or 3: evidence-based recommendation from the Multisociety Italian Guidelines for cervical cancer prevention[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 1039-1047.
[8] Gian Marco Prandi, Silvia Cocchio, Marco Fonzo, Patrizia Furlan, Michele Nicoletti, Vincenzo Baldo. Towards the elimination of cervical cancer: HPV epidemiology, real-world experiences and the potential impact of the 9-valent HPV vaccine[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 1068-1078.
[9] Paolo Giorgi Rossi, Anna Iossa, Carmen Beatriz Visioli, Francesco Venturelli, Paola Garutti, on behalf of the GISCi working group on follow up after treatment. Development of evidence-based guidelines for follow up of women treated for cervical intraepithelial neoplasia grade 2 or 3 (CIN2/3) in Italian screening programmes[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 1079-1092.
[10] Francesco Venturelli on behalf of the Multisociety Italian Guidelines for cervical cancer prevention Working Group. Developing evidence-based Multisociety Italian Guidelines for cervical cancer prevention: rationale, methods, and development process[J]. European Journal of Gynaecological Oncology, 2021, 42(4): 634-642.
[11] Agnieszka Lewandowska, Lukasz Wicherek, Krzysztof Koper, Sebastian Szubert, Joanna Terlikiewicz, Grzegorz Panek, Marlena Cwynar, Andrzej Roszak, Zaneta Warenczak-Florczak. An analysis of outcomes of patients with locally advanced cervical cancer treated by emergency hysterectomy due to vaginal hemorrhage followed by chemoradiation and surgery in cases of locally advanced cervical cancer[J]. European Journal of Gynaecological Oncology, 2021, 42(4): 682-687.
[12] Maria Szymankiewicz, Sebastian Szubert. Microbiological characteristics of early and late infectious complications following total pelvic exenteration due to cervical cancer recurrence—the significance of infections in long-term outcomes[J]. European Journal of Gynaecological Oncology, 2021, 42(4): 742-751.
[13] Heng Wei, Yang Zhang, Qiao Zhang, Yanming Lu, Yunlong Huo, Ning Wang. Association of the rs2430561 polymorphism of the interferon-𝜸 gene with cervical cancer susceptibility and prognosis in Han Chinese women[J]. European Journal of Gynaecological Oncology, 2021, 42(4): 788-794.
[14] Qihui Feng, Qingli Li, Keyong Bao, Yue Wang, Ping Song, Peng Zuo, Mingzhu Li, Chao Zhao, Na Wang,Jingran Li, Rutie Yin, Lihui Wei. Analysis and comparison of the prevalence and genotype distribution of human papillomavirus in two different areas of China: a cross-sectional study[J]. European Journal of Gynaecological Oncology, 2021, 42(4): 795-801.
[15] Kota Umemura, Yosuke Kawai, Hiroko Machida, Ryosuke Uekusa, Atsushi Kunishima, Mayumi Okada, Hisao Ando, Michiyasu Kawai. An innovative tissue model for robot-assisted radical hysterectomy and pelvic lymphadenectomy[J]. European Journal of Gynaecological Oncology, 2021, 42(3): 482-487.
No Suggested Reading articles found!